The iShares Nasdaq Biotechnology ETF (IBB), the largest biotech-related ETF by assets, closed lower last Friday, but for the week, the fund gained 2%. That could be a sign downtrodden biotech ETFs are poised to bounce back. A 2% weekly gain for a biotech ETF is by no means, but all recoveries have...